MGLL and ovarian serous cystadenocarcinoma: Further cox regression analysis of 38 tumors indicated that MGLL expression significantly correlated with PFS in 5 cancers and was a risk factor for UM (p = 6.0e-7), PAAD (p = 1.7e-3), STAD (p = 4.0e-3), and ACC (p = 0.03), but a protective factor for ovarian serous cystadenocarcinoma (OV, p=0.03; Figure 7C).